ID   BIEA_HUMAN              Reviewed;         296 AA.
AC   P53004; A8K747; O95019; Q86UX0; Q96QL4; Q9BRW8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Biliverdin reductase A;
DE            Short=BVR A;
DE            EC=1.3.1.24;
DE   AltName: Full=Biliverdin-IX alpha-reductase;
DE   Flags: Precursor;
GN   Name=BLVRA; Synonyms=BLVR, BVR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-3.
RX   PubMed=8950184; DOI=10.1016/S0167-4781(96)00099-1;
RA   Komuro A., Tobe T., Nakano Y., Yamaguchi T., Tomita M.;
RT   "Cloning and characterization of the cDNA encoding human biliverdin-IX
RT   alpha reductase.";
RL   Biochim. Biophys. Acta 1309:89-99(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=8631357; DOI=10.1111/j.1432-1033.1996.00372.x;
RA   Maines M.D., Polevoda B.V., Huang T.-J., McCoubrey W.K. Jr.;
RT   "Human biliverdin IXalpha reductase is a zinc-metalloprotein.
RT   Characterization of purified and Escherichia coli expressed enzymes.";
RL   Eur. J. Biochem. 235:372-381(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-3; VAL-37 AND
RP   ARG-56.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-3.
RC   TISSUE=Brain, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 3-36; 48-74 AND 228-248.
RC   TISSUE=Liver;
RX   PubMed=8424666; DOI=10.1006/abbi.1993.1044;
RA   Maines M.D., Trakshel G.M.;
RT   "Purification and characterization of human biliverdin reductase.";
RL   Arch. Biochem. Biophys. 300:320-326(1993).
RN   [8]
RP   PROTEIN SEQUENCE OF 3-22.
RC   TISSUE=Liver;
RX   PubMed=7929092;
RA   Yamaguchi T., Komoda Y., Nakajima H.;
RT   "Biliverdin-IX alpha reductase and biliverdin-IX beta reductase from
RT   human liver. Purification and characterization.";
RL   J. Biol. Chem. 269:24343-24348(1994).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   INVOLVEMENT IN HBLVD.
RX   PubMed=19580635; DOI=10.1111/j.1478-3231.2009.02029.x;
RA   Gafvels M., Holmstrom P., Somell A., Sjovall F., Svensson J.O.,
RA   Stahle L., Broome U., Stal P.;
RT   "A novel mutation in the biliverdin reductase-A gene combined with
RT   liver cirrhosis results in hyperbiliverdinaemia (green jaundice).";
RL   Liver Int. 29:1116-1124(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174 AND SER-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-248 AND LYS-253, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 7-296 IN COMPLEX WITH NADP.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human biliverdin reductase A.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Reduces the gamma-methene bridge of the open
CC       tetrapyrrole, biliverdin IX alpha, to bilirubin with the
CC       concomitant oxidation of a NADH or NADPH cofactor.
CC   -!- CATALYTIC ACTIVITY: Bilirubin + NAD(P)(+) = biliverdin + NAD(P)H.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- PATHWAY: Porphyrin-containing compound metabolism; protoheme
CC       degradation.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|Ref.18}.
CC   -!- INTERACTION:
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-7410441, EBI-739832;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Liver.
CC   -!- DISEASE: Hyperbiliverdinemia (HBLVD) [MIM:614156]: A condition
CC       characterized by a green discoloration of the skin, urine, serum,
CC       and other bodily fluids. It is due to increased biliverdin
CC       resulting from inefficient conversion to bilirubin. Affected
CC       individuals appear to have symptoms only in the context of
CC       obstructive cholestasis and/or liver failure. In some cases, green
CC       jaundice can resolve after resolution of obstructive cholestasis.
CC       {ECO:0000269|PubMed:19580635}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Uses the reactants NADH or NADPH depending on the
CC       pH; NADH is used at the acidic pH range (6-6.9) and NADPH at the
CC       alkaline range (8.5-8.7). NADPH, however, is the probable reactant
CC       in biological systems.
CC   -!- SIMILARITY: Belongs to the Gfo/Idh/MocA family. Biliverdin
CC       reductase subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/blvra/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U34877; AAC35588.1; -; mRNA.
DR   EMBL; X93086; CAA63635.1; -; mRNA.
DR   EMBL; AK291862; BAF84551.1; -; mRNA.
DR   EMBL; AY616754; AAT11126.1; -; Genomic_DNA.
DR   EMBL; AC005189; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004939; AAD05025.1; -; Genomic_DNA.
DR   EMBL; AC004985; AAP21879.1; -; Genomic_DNA.
DR   EMBL; BC005902; AAH05902.1; -; mRNA.
DR   EMBL; BC008456; AAH08456.1; -; mRNA.
DR   CCDS; CCDS5472.1; -.
DR   PIR; G02066; G02066.
DR   PIR; S62624; S62624.
DR   RefSeq; NP_000703.2; NM_000712.3.
DR   RefSeq; NP_001240752.1; NM_001253823.1.
DR   RefSeq; XP_011513776.1; XM_011515474.2.
DR   RefSeq; XP_016868009.1; XM_017012520.1.
DR   UniGene; Hs.488143; -.
DR   PDB; 2H63; X-ray; 2.70 A; A/B/C/D=7-296.
DR   PDBsum; 2H63; -.
DR   ProteinModelPortal; P53004; -.
DR   SMR; P53004; -.
DR   BioGrid; 107113; 16.
DR   DIP; DIP-42180N; -.
DR   IntAct; P53004; 2.
DR   MINT; MINT-1212210; -.
DR   STRING; 9606.ENSP00000265523; -.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P53004; -.
DR   PhosphoSitePlus; P53004; -.
DR   BioMuta; BLVRA; -.
DR   DMDM; 23830892; -.
DR   OGP; P53004; -.
DR   REPRODUCTION-2DPAGE; IPI00294158; -.
DR   EPD; P53004; -.
DR   MaxQB; P53004; -.
DR   PaxDb; P53004; -.
DR   PeptideAtlas; P53004; -.
DR   PRIDE; P53004; -.
DR   Ensembl; ENST00000265523; ENSP00000265523; ENSG00000106605.
DR   Ensembl; ENST00000402924; ENSP00000385757; ENSG00000106605.
DR   GeneID; 644; -.
DR   KEGG; hsa:644; -.
DR   UCSC; uc003tir.4; human.
DR   CTD; 644; -.
DR   DisGeNET; 644; -.
DR   GeneCards; BLVRA; -.
DR   HGNC; HGNC:1062; BLVRA.
DR   HPA; HPA019709; -.
DR   HPA; HPA042865; -.
DR   HPA; HPA054322; -.
DR   MalaCards; BLVRA; -.
DR   MIM; 109750; gene.
DR   MIM; 614156; phenotype.
DR   neXtProt; NX_P53004; -.
DR   OpenTargets; ENSG00000106605; -.
DR   Orphanet; 276405; Hyperbiliverdinemia.
DR   PharmGKB; PA25373; -.
DR   eggNOG; ENOG410IH7U; Eukaryota.
DR   eggNOG; ENOG4111FZX; LUCA.
DR   GeneTree; ENSGT00390000011072; -.
DR   HOGENOM; HOG000231884; -.
DR   HOVERGEN; HBG003218; -.
DR   InParanoid; P53004; -.
DR   KO; K00214; -.
DR   OMA; NMPNVGV; -.
DR   OrthoDB; EOG091G0E2N; -.
DR   PhylomeDB; P53004; -.
DR   TreeFam; TF342889; -.
DR   BioCyc; MetaCyc:HS02928-MONOMER; -.
DR   BRENDA; 1.3.1.24; 2681.
DR   Reactome; R-HSA-189483; Heme degradation.
DR   SIGNOR; P53004; -.
DR   UniPathway; UPA00684; -.
DR   ChiTaRS; BLVRA; human.
DR   EvolutionaryTrace; P53004; -.
DR   GenomeRNAi; 644; -.
DR   PRO; PR:P53004; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106605; -.
DR   CleanEx; HS_BLVRA; -.
DR   ExpressionAtlas; P53004; baseline and differential.
DR   Genevisible; P53004; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004074; F:biliverdin reductase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0042167; P:heme catabolic process; TAS:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   InterPro; IPR017094; Biliverdin_Rdtase_A.
DR   InterPro; IPR015249; Biliverdin_Rdtase_cat.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR000683; Oxidoreductase_N.
DR   Pfam; PF09166; Biliv-reduc_cat; 1.
DR   Pfam; PF01408; GFO_IDH_MocA; 1.
DR   PIRSF; PIRSF037032; Biliverdin_reductase_A; 1.
DR   ProDom; PD040165; Biliverdin_Rdtase_cat; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Metal-binding; NAD; NADP; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Zinc.
FT   PROPEP        1      2       {ECO:0000269|PubMed:7929092,
FT                                ECO:0000269|PubMed:8424666}.
FT                                /FTId=PRO_0000010852.
FT   CHAIN         3    296       Biliverdin reductase A.
FT                                {ECO:0000269|PubMed:8631357}.
FT                                /FTId=PRO_0000010853.
FT   NP_BIND      15     20       NAD or NADP.
FT   NP_BIND      44     46       NAD or NADP.
FT   NP_BIND      77     80       NAD or NADP.
FT   COMPBIAS     11     16       Poly-Val.
FT   METAL       280    280       Zinc. {ECO:0000255}.
FT   METAL       281    281       Zinc. {ECO:0000255}.
FT   METAL       292    292       Zinc. {ECO:0000255}.
FT   METAL       293    293       Zinc. {ECO:0000255}.
FT   BINDING      98     98       NAD or NADP; via carbonyl oxygen.
FT   MOD_RES     174    174       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     178    178       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     230    230       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     248    248       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     253    253       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT       3      3       A -> T (in dbSNP:rs699512).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8950184,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019230.
FT   VARIANT      37     37       L -> V (in dbSNP:rs17245918).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019231.
FT   VARIANT      56     56       Q -> R (in dbSNP:rs1050916).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014851.
FT   CONFLICT    121    121       L -> S (in Ref. 6; AAH05902).
FT                                {ECO:0000305}.
FT   CONFLICT    154    155       AG -> SD (in Ref. 2; CAA63635).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       E -> D (in Ref. 2; CAA63635).
FT                                {ECO:0000305}.
FT   STRAND        9     14       {ECO:0000244|PDB:2H63}.
FT   HELIX        18     28       {ECO:0000244|PDB:2H63}.
FT   HELIX        33     36       {ECO:0000244|PDB:2H63}.
FT   STRAND       37     43       {ECO:0000244|PDB:2H63}.
FT   STRAND       50     53       {ECO:0000244|PDB:2H63}.
FT   HELIX        59     64       {ECO:0000244|PDB:2H63}.
FT   STRAND       70     73       {ECO:0000244|PDB:2H63}.
FT   HELIX        77     89       {ECO:0000244|PDB:2H63}.
FT   STRAND       93     98       {ECO:0000244|PDB:2H63}.
FT   HELIX       104    117       {ECO:0000244|PDB:2H63}.
FT   STRAND      121    124       {ECO:0000244|PDB:2H63}.
FT   HELIX       126    129       {ECO:0000244|PDB:2H63}.
FT   HELIX       131    140       {ECO:0000244|PDB:2H63}.
FT   STRAND      145    154       {ECO:0000244|PDB:2H63}.
FT   HELIX       159    162       {ECO:0000244|PDB:2H63}.
FT   HELIX       165    168       {ECO:0000244|PDB:2H63}.
FT   HELIX       170    180       {ECO:0000244|PDB:2H63}.
FT   STRAND      182    193       {ECO:0000244|PDB:2H63}.
FT   STRAND      198    207       {ECO:0000244|PDB:2H63}.
FT   STRAND      212    219       {ECO:0000244|PDB:2H63}.
FT   STRAND      226    235       {ECO:0000244|PDB:2H63}.
FT   HELIX       250    262       {ECO:0000244|PDB:2H63}.
FT   HELIX       268    290       {ECO:0000244|PDB:2H63}.
SQ   SEQUENCE   296 AA;  33428 MW;  2CF2AA7F1CDDB707 CRC64;
     MNAEPERKFG VVVVGVGRAG SVRMRDLRNP HPSSAFLNLI GFVSRRELGS IDGVQQISLE
     DALSSQEVEV AYICSESSSH EDYIRQFLNA GKHVLVEYPM TLSLAAAQEL WELAEQKGKV
     LHEEHVELLM EEFAFLKKEV VGKDLLKGSL LFTAGPLEEE RFGFPAFSGI SRLTWLVSLF
     GELSLVSATL EERKEDQYMK MTVCLETEKK SPLSWIEEKG PGLKRNRYLS FHFKSGSLEN
     VPNVGVNKNI FLKDQNIFVQ KLLGQFSEKE LAAEKKRILH CLGLAEEIQK YCCSRK
//
